Salubrinal is a drug which acts as a specific inhibitor of EIF2S1, eIF2α phosphatase enzymes and is primarily used experimentally, to study stress responses in eukaryotic cell (biology), cells associated with the action of eIF2. Salubrinal indirectly inhibits eIF2 as a result of reduced phosphorylation, dephosphorylation of its α-protein subunit, subunit, resulting in activation of stress response pathways usually triggered by events such as oxidative stress or buildup of unfolded protein in the endoplasmic reticulum. Salubrinal has putative therapeutic value due to its function, but is as yet only used experimentally. Salubrinal is being studied at Indiana University for its potential to fight osteoporosis and accelerate bone healing.

References

{{Reflist, refs= {{cite journal , vauthors = Kessel D , title = Protection of Bcl-2 by salubrinal , journal = Biochemical and Biophysical Research Communications , volume = 346 , issue = 4 , pages = 1320–3 , date = August 2006 , pmid = 16806073 , pmc = 2978664 , doi = 10.1016/j.bbrc.2006.06.056 , publisher = Elsevier Inc {{dead link, date=March 2019, bot=medic{{cbignore, bot=medic {{cite journal , vauthors = Lewerenz J, Maher P , title = Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression , journal = The Journal of Biological Chemistry , volume = 284 , issue = 2 , pages = 1106–15 , date = January 2009 , pmid = 19017641 , pmc = 2613630 , doi = 10.1074/jbc.M807325200 , publisher = The American Society for Biochemistry and Molecular Biology, Inc , doi-access = free {{cite journal , vauthors = Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D, Kaufman RJ, Ma D, Coen DM, Ron D, Yuan J , display-authors = 6 , title = A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress , journal = Science , volume = 307 , issue = 5711 , pages = 935–9 , date = February 2005 , pmid = 15705855 , doi = 10.1126/science.1101902 , bibcode = 2005Sci...307..935B , s2cid = 86257684 , url = http://www.sciencemag.org/cgi/content/abstract/307/5711/935 {{cite web, title=Entrez Gene: EIF2S1 eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa, url=https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1965, access-date=2010-10-05, publisher= National Center for Biotechnology Information, U.S. National Library of Medicine {{cite journal , vauthors = Wek RC, Jiang HY, Anthony TG , title = Coping with stress: eIF2 kinases and translational control , journal = Biochemical Society Transactions , volume = 34 , issue = Pt 1 , pages = 7–11 , date = February 2006 , pmid = 16246168 , doi = 10.1042/BST20060007 , publisher = Biochemical Society {{cite web , title=New compound may accelerate bone healing, prevent osteoporosis, url = http://www.cloningresources.com/research/New_compound_may_accelerate_bone_healing_prevent_osteoporosis.asp , archive-url = https://web.archive.org/web/20110929162126/http://www.cloningresources.com/research/New_compound_may_accelerate_bone_healing_prevent_osteoporosis.asp , archive-date = 29 September 2011 , access-date=2011-08-29 , date=August 2011 Drugs not assigned an ATC code Thioureas Quinolines Organochlorides